Sarcoma, Ewing: all 290 studies
Page 3 of 3. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.
- Trabectedin and Irinotecan for Refractory Pediatric SarcomasStatus unknownNCT02509234
- Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings SarcomaCompletedNCT02472392Phase 1
- Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue SarcomasCompletedNCT02415816Not applicable
- Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for SarcomasStatus unknownNCT02409576Phase 1/2
- Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsCompletedNCT02390843Phase 1
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable
- Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A AntibodyCompletedNCT02159443
- MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid TumorsCompletedNCT02076906Phase 1
- Efficacy of Dose Intensification in Patients With Non-metastatic Ewing SarcomaCompletedNCT02063022Phase 3
- ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing SarcomaCompletedNCT02044120Phase 1
- Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid TumorsWithdrawnNCT02011126Phase 2
- A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing SarcomaWithdrawnNCT01969942Phase 1
- Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing SarcomaTerminatedNCT01882231Not applicable
- Genetic Biomarkers in Saliva Samples From Patients With Ewing SarcomaCompletedNCT01876303
- Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or RhabdoomyosarcomaCompletedNCT01858168Phase 1
- 18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing SarcomaCompletedNCT01825902Early Phase 1
- Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid TumorsStatus unknownNCT01807468Phase 2
- Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing SarcomaWithdrawnNCT01795430Not applicable
- Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young AdultsStatus unknownNCT01780779
- Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma PatientsWithdrawnNCT01734863Phase 3
- Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young AdultsCompletedNCT01696669Phase 2
- Effects of Preoperative Physical Therapy in Patients With Lower Extremity MalignancyCompletedNCT01674101Not applicable
- Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid TumorsCompletedNCT01661400Phase 1
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedNCT01625351Phase 1
- Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated GangliosidesCompletedNCT01598454Phase 1
- PK/PD of XM22 in Children With Ewing Family of Tumors or RhabdomyosarcomaCompletedNCT01585649Phase 1
- Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid TumorsCompletedNCT01518413Phase 1
- Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and VomitingWithdrawnNCT01492569Not applicable
- Biomarkers in Tissue Samples From Patients With Ewing SarcomaCompletedNCT01480518
- Biomarker in Tissue Samples From Patients With Ewing SarcomaCompletedNCT01365949
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 1
- A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens AloneCompletedNCT01288573Phase 1/2
- Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and SarcomaCompletedNCT01241162Phase 1
- Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable
- Study of Blood Samples From Patients With Ewing Sarcoma and Their RelativesCompletedNCT01210209
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsCompletedNCT01169584Phase 1
- Markers of Anthracycline-Related Cardiac Muscle InjuryWithdrawnNCT01112800
- Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced CancerCompletedNCT01061840Phase 1
- Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues SarcomasStatus unknownNCT00998361Phase 2
- Study in Localized and Disseminated Ewing SarcomaCompletedNCT00987636Phase 3
- HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsCompletedNCT00931931Phase 1
- Informed Consent in Pediatric Cancer TrialsCompletedNCT00923650
- Collecting and Storing Biological Samples From Patients With Ewing SarcomaCompletedNCT00899990
- Collecting and Storing Tissue From Young Patients With CancerCompletedNCT00898755
- Study of Tumor Samples From Patients With Ewing SarcomaCompletedNCT00898053
- Methionine PET/CT Studies In Patients With CancerActive, not recruitingNCT00840047Phase 2
- Functional and Clinical Long-Term Outcome of Ewing Sarcoma TreatmentCompletedNCT00824083
- A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and MelanomaCompletedNCT00743496Phase 1
- Evaluating Dactinomycin and Vincristine in Young Patients With CancerCompletedNCT00674193
- Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorCompletedNCT00638898Phase 1
- IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid TumorCompletedNCT00609141Phase 1
- Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)TerminatedNCT00568464Phase 2
- QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell TumorsCompletedNCT00563680Phase 2
- Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's SarcomaStatus unknownNCT00541411Not applicable
- Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the LungCompletedNCT00503295Phase 2
- Aerosol L9-NC and Temozolomide in Ewing's SarcomaCompletedNCT00492141Phase 1/2
- HGS-ETR2 to Treat Children With Solid TumorsTerminatedNCT00428272Phase 1
- Prognostic Value of a Positive RT-PCR Test in Patients With Ewing SarcomaCompletedNCT00339898
- Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's SarcomaWithdrawnNCT00334867Phase 3
- Ixabepilone in Treating Young Patients With Refractory Solid TumorsCompletedNCT00331643Phase 2
- Irinotecan in Treating Patients With Newly Diagnosed Ewing's SarcomaCompletedNCT00276692Phase 2
- Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in RelapseStatus unknownNCT00180947Phase 2
- Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid TumorsStatus unknownNCT00179816Phase 1/2
- Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and SarcomasCompletedNCT00165139Phase 2
- Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsTerminatedNCT00110032Phase 1
- Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or NeuroblastomaStatus unknownNCT00101309Phase 1
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsCompletedNCT00093821Phase 1
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell TumorCompletedNCT00062205Phase 2
- Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell TumorCompletedNCT00055952Phase 2
- Diagnostic Study of Tumor Characteristics in Patients With Ewing's SarcomaCompletedNCT00048984
- Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
- Eligibility Screening for a NCI Pediatric Oncology Branch Research StudyCompletedNCT00026780
- Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 1
- Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal TumorTerminatedNCT00014313Phase 2
- Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal TumorCompletedNCT00006734Phase 3
- Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the BoneCompletedNCT00006234Phase 1/2
- Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyCompletedNCT00004853Phase 1
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaCompletedNCT00004241Phase 1
- Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
- Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's SarcomaCompletedNCT00003667Phase 2
- Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or RhabdomyosarcomaCompletedNCT00003081Phase 1
- Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's SarcomaStatus unknownNCT00002516Phase 3
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone CancerCompletedNCT00002466Phase 2
- Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare DiseasesCompletedNCT00001686
- A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric SarcomasCompletedNCT00001564Phase 2
- New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and NeuroblastomaCompletedNCT00001335Phase 2
- A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal TumorsCompletedNCT00001209Phase 1